Findings being presented in San Francisco show which patients may be able to stop anti-TNF therapy, and which ones will do well with conventional drugs as second-line treatment. A test that predicts ...

Equipped with a blood test capable of predicting an individual’s response—or lack thereof—to the world’s largest drug class, Scipher Medicine is on its way to cracking the code of rheumatoid arthritis ...

Q: Can you tell me the name of the blood test that would tell me if I have rheumatoid arthritis? A: Actually, there is no blood test that’ll tell you if you have rheumatoid arthritis — an inflammatory ...

Results presented today at the American College of Rheumatology in Boston show that a 12-biomarker test did a better job of predicting radiographic progression in patients with RA. The study ...

Myriad Genetics ($MYGN) touted three studies at the meeting of the American College of Rheumatology in San Francisco showing that its Vectra DA diagnostic for ...

Although there are more than 100 conditions that fall under the umbrella term "arthritis," an autoimmune disease called rheumatoid arthritis is one of the more common. According to the Arthritis ...

Please provide your email address to receive an email when new articles are posted on . If there was any question about whether rheumatologists would utilize an effective biomarker that can predict ...

Seven years ago, Northeastern graduate Susan Dina Ghiassian was the first employee of Scipher Medicine Corp., a precision medicine company co-founded by Northeastern professor Albert-László Barabási.

Please provide your email address to receive an email when new articles are posted on . When it comes to informing treatment decisions, rheumatologists value patient-reported symptoms and physical ...